GlassScriptPhysician profile
Matthew R Levin
NPI 1356780415
$970.36
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $228.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $175.57 | 2019-2020 | |
| Abbvie INC. | $158.29 | 2019-2020 | |
| Pfizer INC. | $89.76 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $79.07 | 2019 | |
| Corcept Therapeutics | $67.55 | 2019-2020 | |
| Gilead Sciences, INC. | $46.28 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $36.68 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $36.34 | 2019 | |
| Amgen INC. | $35.78 | 2020 | |
| Amarin Pharma, INC. | $34.82 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $29.01 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.26 | 2019-2020 | |
| Dentsply Sirona INC | $20.93 | 2019 | |
| Horizon Therapeutics Plc | $19.18 | 2020 | |
| Avanir Pharmaceuticals, INC. | $18.30 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.97 | 2019 | |
| Dynavax Technologies Corporation | $15.38 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.31 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.79 | 2019 | |
| Mannkind Corporation | $13.06 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.16 | 2019 | |
| Merck Sharp & Dohme LLC | $10.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.